News

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...
HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.
WASHINGTON -- The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.
But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.